Venture Partners L P Sofinnova VI's Net Worth
-$14.9 Million
Who is Venture Partners L P Sofinnova VI?
Venture Partners L P Sofinnova VI does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, Anthera Pharmaceuticals Inc, and Ocera Therapeutics, Inc..
SEC CIK
Venture Partners L P Sofinnova VI's CIK is 0001211465
Past Insider Trading and Trends
2010 was Venture Partners L P Sofinnova VI's most active year for acquiring shares with 24 total transactions. Venture Partners L P Sofinnova VI's most active month to acquire stocks was the month of February. 2007 was Venture Partners L P Sofinnova VI's most active year for disposing of shares, totalling 9 transactions. Venture Partners L P Sofinnova VI's most active month to dispose stocks was the month of February. 2010 saw Venture Partners L P Sofinnova VI paying a total of $12,560,454.34 for 4,177,621 shares, this is the most they've acquired in one year. In 2007 Venture Partners L P Sofinnova VI cashed out on 5,645,711 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $1.3911
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.31% | -750.68K |
$1.39 | -$1,042,698.68 | 1.38M |
Oct 20
| |||
Form 4
| +71.72% | 2.13M |
$8.00 | $6,005,464.00 | 5.09M |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Anthera Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +30.31% | 4.07M |
$6.13 | $12,560,454.34 | 17.51M |
Mar 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +82.80% | 2.82M |
—
|
—
| 6.23M |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ocera Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.00% | -410.02K |
—
|
—
| 832.47K |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +45.95% | 391.17K |
$6.03 | $2,357,322.78 | 1.24M |
Jul 15
| |||
No matching records found |